CTIS2022-501428-45-00招募中1 期
The DEXA-PSYCH Study: Dexamethasone Repurposing for Moderate to Severe Depression - A Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Trial
Region Hovedstadens Psykiatriske0 个研究点目标入组 300 人开始时间: 2022年7月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- •Diagnosis of non-psychotic, moderate to severe depressive disorder (single episode or recurrent) by a medical doctor according to ICD-10 criteria (ICD-10 codes: F32.1, F32.2, F33.1, F33.2) as operationalized in the Schedule for Clinical Assessment in Neuropsychiatry (SCAN), Section 6-8, A score of 22 or above on the MADRS10 scale at day 0, Age between 18 and 64 years (both included) at the date of enrollment, Habile (i.e. able to give informed consent), Speaks Danish fluently, Are currently receiving pharmacological treatment for depression
排除标准
- •Have a known hypersensitivity to glucocorticoid treatment (including any drug in the glucocorticoid class) either explicitly stated in the patient journal or known to the patient from prior glucocorticoid treatment, Are currently undergoing treatment with potassium-depleting diuretics, Are currently undergoing immunosuppressive treatments or treatments affecting the CYP3A4 system (i.e. erythromycin, itraconazole, ritonavir, lopinavir, phenobarbital, phenytoin, rifampicin), Have undergone treatment with monoamine oxidase (MAO) inhibitors in the last 14 days, Are pregnant (i.e. fertile woman below 60 with a positive urine or plasma human gonadotropin test), currently breast-feeding or not adherent to a sufficient anticontraceptive plan, Are undergoing or have undergone systemic (oral or intravenous) treatment with any drug in the glucocorticoid class within the last 14 days, Have previously been diagnosed with a psychotic disorder (including depression with psychotic symptoms), personality disorder, eating disorder or bipolar disorder, Have experienced or are experiencing manic and/or hypomanic episodes as uncovered according to section 10 of the SCAN assessment, Are currently using psychoactive substances and fulfill ICD-10 criteria for harmful use (F1X.1) or dependence syndrome (F1X.2.), Have a known 1st degree family history of bipolar disorder (i.e. among parents, siblings and children), Are diagnosed with disorders that are listed as contra-indications for glucocorticoid treatment in Danish guidelines including immunodeficiencies, systemic fungal infections, active tuberculosis, hematological malignancies, epilepsy, myasthenia gravis, ocular herpes simplex, pheochromocytoma, systemic sclerosis or acute coronary syndrome (within the last 6 months), Have prolonged QTc-interval on ECG (>480 ms), Have clinically significant reduction in liver function (ALT >2.5 x upper limit of normal range, ULN: men >70 U/l, women >45 U/l), Have diagnosed diabetes mellitus or suspected diabetes mellitus (as measured by HbA1c of >45 mmol/mol), Have suicidal plans, Have undergone electroconvulsive treatment (ECT) or transcranial magnetic stimulation (TMS) within the last 2 weeks, Have been vaccinated within 14 days before intervention initiation or is planning on being vaccinated during the intervention or within 14 days after the vaccination
研究者
相似试验
招募中
1 期
Investigating the effect of dexamethasone administration on the progress of labor in pregnant women referred to Hospital .IRCT20231002059592N1Sanandaj University of Medical Sciences120
已完成
不适用
Evaluation of the effects of using Dexamethasone impregnated gel foam and local injection of Dexamethasone in reduction of post impacted third molar surgery side effects in patients referring to Bushehr University of Medical Sciences Dental clinicCondition 1: Post opreative pain. Condition 2: Trismus.Other specified disorders of teeth and supporting structuresCramp and spasmK08.8R25.2IRCT20201101049209N1Boushehr University of Medical Sciences114
进行中（未招募）
1 期
Dexamethasone in community-acquired pneumonia.Patients with a community-acquired pneumonia who are admitted to the hospital.EUCTR2011-004566-14-NL600
尚未招募
不适用
A study to assess the efficacy of Dexamethasone as an adjuvant in ultrasound guided cervical plexus block using Bupivacaine 0.25% in patients undergoing thyroid surgery under general anesthesiaCTRI/2021/04/032612Dr Archana M
已完成
不适用
A study to establish the efficacy of dexamethasone used in combination with cyclizine in the prevention of post operative nausea and vomitingISRCTN18556628Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)150